Related Experiment Video
Updated: Jun 29, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Neural-network detection of hypoglycemic episodes in children with type 1 diabetes using physiological parameters
Hung T Nguyen1, Nejhdeh Ghevondian, Timothy W Jones
1Key Univ. Res. Centre for Health Technol., Univ. of Technol., Sydney, NSW, Australia.
Abstract:
The most common and highly feared adverse effect of intensive insulin therapy in patients with diabetes is the increased risk of hypoglycemia. Symptoms of hypoglycemia arise from the activation of the autonomous central nervous systems and from reduced cerebral glucose consumption. HypoMon is a non-invasive monitor that measures some physiological parameters continuously to provide detection of hypoglycemic episodes in Type 1 diabetes mellitus patients (T1DM). Based on heart rate, corrected QT interval of the ECG signal and skin impedance, a neural network detection algorithm has been developed to recognize the presence of hypoglycemic episodes. From a clinical study of 21 children with T1DM, associated with hypoglycemic episodes, their heart rates increased (1.16 +/- 0.16 vs. 1.03 +/- 0.11, P<0.0001), their corrected QT intervals increased (1.09 +/- 0.09 vs. 1.02 +/- 0.07, P<0.0001) and their skin impedances reduced significantly (0.66 +/- 0.19 vs. 0.82 +/- 0.21, P<0.0001). The overall data were obtained and grouped into a training set, a validation set and a test set, each with 7 patients randomly selected. Using a feedforward multi-layer neural network with 9 hidden nodes, and an algorithm developed from the training set and the validation set, a sensitivity of 0.9516 and specificity of 0.4142 were achieved for the test set. A more advanced neural network algorithm will be developed to improve the specificity of test sets in the near future.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon
Type I Diabetes III: Clinical Manifestations
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Hypoglycemia
Hyperglycemia

